| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comprehensive landscape of transcription profiles and data resources for human leukemia
|
Luo, Mei
|
|
|
7 |
14 |
p. 3435-3449
|
article
|
| 2 |
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
|
Komrokji, Rami S.
|
|
|
7 |
14 |
p. 3677-3679
|
article
|
| 3 |
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
|
Cuvelier, Geoffrey D. E.
|
|
|
7 |
14 |
p. 3612-3623
|
article
|
| 4 |
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT
|
Geerlinks, Ashley V.
|
|
|
7 |
14 |
p. 3725-3734
|
article
|
| 5 |
Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study
|
Scott, Stuart
|
|
|
7 |
14 |
p. 3686-3694
|
article
|
| 6 |
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
|
Shouse, Geoffrey
|
|
|
7 |
14 |
p. 3516-3529
|
article
|
| 7 |
BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
|
Jackson, Ross A.
|
|
|
7 |
14 |
p. 3378-3381
|
article
|
| 8 |
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
|
Ferrero, Simone
|
|
|
7 |
14 |
p. 3764-3774
|
article
|
| 9 |
Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead
|
Pasvolsky, Oren
|
|
|
7 |
14 |
p. 3350-3360
|
article
|
| 10 |
Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
|
Herzog, Shannon
|
|
|
7 |
14 |
p. 3644-3650
|
article
|
| 11 |
Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
|
Karol, Seth E.
|
|
|
7 |
14 |
p. 3651-3657
|
article
|
| 12 |
Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease
|
Hoyt, Catherine R.
|
|
|
7 |
14 |
p. 3680-3682
|
article
|
| 13 |
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
|
Qualls, David
|
|
|
7 |
14 |
p. 3469-3471
|
article
|
| 14 |
Correcting the record on anemia of aging: a statistical reanalysis
|
Fell, Geoffrey G.
|
|
|
7 |
14 |
p. 3642-3643
|
article
|
| 15 |
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP
|
Georgi, Julia-Annabell
|
|
|
7 |
14 |
p. 3710-3724
|
article
|
| 16 |
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma
|
Che, Yuxuan
|
|
|
7 |
14 |
p. 3361-3365
|
article
|
| 17 |
Editorial Board
|
|
|
|
7 |
14 |
p. i
|
article
|
| 18 |
EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts
|
Wu, Ji
|
|
|
7 |
14 |
p. 3382-3394
|
article
|
| 19 |
Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia
|
Olivera, Joseph
|
|
|
7 |
14 |
p. 3339-3349
|
article
|
| 20 |
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
|
Usmani, Saad Z.
|
|
|
7 |
14 |
p. 3739-3748
|
article
|
| 21 |
Front Matter
|
|
|
|
7 |
14 |
p. ii
|
article
|
| 22 |
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
|
Abel, Gregory A.
|
|
|
7 |
14 |
p. 3506-3515
|
article
|
| 23 |
Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function
|
Kikushige, Yoshikane
|
|
|
7 |
14 |
p. 3592-3603
|
article
|
| 24 |
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
|
Watanabe, Keisuke
|
|
|
7 |
14 |
p. 3416-3430
|
article
|
| 25 |
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
|
Short, Nicholas J.
|
|
|
7 |
14 |
p. 3573-3581
|
article
|
| 26 |
Kennedy VE, Wong C, Huang C-Y, et al. Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Blood Adv. 2021;5(23):5344-5348.
|
|
|
|
7 |
14 |
p. 3540
|
article
|
| 27 |
Liem RI, Lanzkron S, Coates TD, et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3(23):3867-3897.
|
|
|
|
7 |
14 |
p. 3530
|
article
|
| 28 |
Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
|
Johnson, P. Connor
|
|
|
7 |
14 |
p. 3541-3550
|
article
|
| 29 |
Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells
|
Chang, Yu-Tai
|
|
|
7 |
14 |
p. 3551-3560
|
article
|
| 30 |
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma
|
Tatarczuch, Maciej
|
|
|
7 |
14 |
p. 3531-3539
|
article
|
| 31 |
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
|
Verstovsek, Srdan
|
|
|
7 |
14 |
p. 3582-3591
|
article
|
| 32 |
Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
|
Liang, Emily C.
|
|
|
7 |
14 |
p. 3395-3402
|
article
|
| 33 |
Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL
|
Levinson, Anya L.
|
|
|
7 |
14 |
p. 3479-3484
|
article
|
| 34 |
Physioxia improves the selectivity of hematopoietic stem cell expansion cultures
|
Igarashi, Kyomi J.
|
|
|
7 |
14 |
p. 3366-3377
|
article
|
| 35 |
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
|
Nannya, Yasuhito
|
|
|
7 |
14 |
p. 3624-3636
|
article
|
| 36 |
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
|
Loke, Justin
|
|
|
7 |
14 |
p. 3666-3676
|
article
|
| 37 |
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms
|
Isabelle, Colleen
|
|
|
7 |
14 |
p. 3637-3641
|
article
|
| 38 |
Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
|
Mucalo, Lana
|
|
|
7 |
14 |
p. 3658-3665
|
article
|
| 39 |
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
|
Al Tabaa, Yassine
|
|
|
7 |
14 |
p. 3735-3738
|
article
|
| 40 |
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
|
Lin, Richard J.
|
|
|
7 |
14 |
p. 3501-3505
|
article
|
| 41 |
PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation
|
Al-Homsi, A. Samer
|
|
|
7 |
14 |
p. 3604-3611
|
article
|
| 42 |
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
|
Kalac, Matko
|
|
|
7 |
14 |
p. 3760-3763
|
article
|
| 43 |
Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand
|
van Beek, Jasper J. P.
|
|
|
7 |
14 |
p. 3458-3468
|
article
|
| 44 |
Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets
|
Norris, Peter A. A.
|
|
|
7 |
14 |
p. 3561-3572
|
article
|
| 45 |
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
|
Schieber, Timothy
|
|
|
7 |
14 |
p. 3431-3434
|
article
|
| 46 |
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
|
Gelli, Elisa
|
|
|
7 |
14 |
p. 3472-3478
|
article
|
| 47 |
The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma
|
Findlay, Steven
|
|
|
7 |
14 |
p. 3485-3500
|
article
|
| 48 |
The value of the old and the new
|
Monagle, Paul
|
|
|
7 |
14 |
p. 3683-3685
|
article
|
| 49 |
Unraveling the genetics of transformed splenic marginal zone lymphoma
|
Grau, Marta
|
|
|
7 |
14 |
p. 3695-3709
|
article
|
| 50 |
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
|
Tuyet Kristensen, Daniel
|
|
|
7 |
14 |
p. 3450-3457
|
article
|
| 51 |
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
|
DeZern, Amy E.
|
|
|
7 |
14 |
p. 3749-3759
|
article
|
| 52 |
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia
|
Engelmann, Robby
|
|
|
7 |
14 |
p. 3403-3415
|
article
|
Journal description